SHL Medical AG

SHL Medical is a global leader in designing, developing, and manufacturing advanced drug delivery devices such as autoinjectors and pen injectors for the pharmaceutical and biotechnology industries. Headquartered in Zug, Switzerland, the company provides vertically integrated end-to-end solutions, including device design, engineering, precision tooling, scale-up, automated assembly, labeling, and packaging. Their modular platforms, such as the flagship Molly autoinjector series, offer flexible options for large-volume and high-viscosity formulations. Serving over 75 markets worldwide, SHL Medical supports combination products across 12 therapeutic areas including endocrinology, cardiovascular, neurology, dermatology, and oncology. The organization operates world-class manufacturing, research, and design facilities in Switzerland, the United States, Taiwan, and Sweden. As an established contract development and manufacturing organization for medical self-injection devices, SHL Medical partners with top biopharmaceutical firms to streamline time-to-market. With more than 6,000 employees globally, the company has shipped over 1.5 billion autoinjectors to date to empower patient independence in self-treatment therapies. SHL Medical maintains EcoVadis Gold status and ISCC PLUS certifications to drive sustainable device manufacturing practices worldwide.